Trials / Completed
CompletedNCT02030704
CCTA-based Coronary Plaque Characterization and High-sensitive Troponin T for the Prediction of Cardiovascular Outcomes
Comprehensive 'Bio-Imaging' Using Quantitative Coronary Plaque Composition Assessment and the High-sensitive Troponin T for the Prediction of Cardiac Outcomes.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- University Hospital Heidelberg · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
To determine the ability of semi-automated plaque assessment in cardiac computed tomography angiography (CCTA) and high sensitive troponin T (hsTnT) for the risk stratification of patients at intermediate risk for coronary artery disease (CAD).
Conditions
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2018-09-01
- Completion
- 2018-09-01
- First posted
- 2014-01-08
- Last updated
- 2018-09-11
Locations
2 sites across 2 countries: Germany, Hungary
Source: ClinicalTrials.gov record NCT02030704. Inclusion in this directory is not an endorsement.